About Euphrates Vascular
Euphrates Vascular is a private company based in St. Louis, Missouri, incorporated in 2018 in Delaware. It has reported $9,674,802 raised in two offerings on Form D since September 2018.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 15, 2020 | Jun 1, 2021amended Oct 3, 2023 | $9,084,802fully sold | 33 | $275K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Aug 31, 2018 | Sep 17, 2018 | $590,000of $4.0M target | 4 | $147K | DebtRule 506(b) | Form D ↗ |
| Total, two offerings | $9,674,802 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Euphrates Vascular's Form D filed Oct 3, 2023.
Earlier filings also listed Troy Long (executive officer, last listed Sep 2018), Timothy Blair (executive officer, last listed Sep 2018), Thomas Hillman (director, last listed Sep 2018), Robert Mitchell (director, last listed Sep 2018), Jeffrey Blair (director, last listed Sep 2018) and Eric Moessinger (director, last listed Sep 2018).